These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

87 related articles for article (PubMed ID: 21899090)

  • 1. [The absence of tolerance and withdrawal syndrome after the treatment with the new L-tryptophane-containing dipeptide anxiolytic GB-115].
    Kolik LG; Garibova TL; Litvinova SA; Kuznetsova AL; Kapitsa IG; Kadnikov IA; Konstantinopol'skiĭ MA; Gudasheva TA; Voronina TA; Seredenin SB
    Vestn Ross Akad Med Nauk; 2011; (7):37-42. PubMed ID: 21899090
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Effect of GB-115 dipeptide on anxiety in rats with model benzodiazepine withdrawal syndrome].
    Kolik LG; Kadnikov IA; Zhukov VN; Gudasheva TA; Seredenin SB
    Eksp Klin Farmakol; 2011; 74(10):7-11. PubMed ID: 22238979
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Neuropharmacology of a new potential anxiolytic compound, F 2692, 1-(3'-trifluoromethyl phenyl) 1, 4-dihydro 3-amino 4-oxo 6-methyl pyridazine. 2. Evaluation of its tolerance and dependence producing potential and of its effects on benzodiazepine withdrawal in the elevated plus-maze test in rats.
    Chopin P; Assié MB; Briley M
    Psychopharmacology (Berl); 1993; 110(1-2):19-26. PubMed ID: 7870883
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Analysis of the chronic intake of and withdrawal from diazepam on emotional reactivity and sensory information processing in rats.
    De Ross J; Castilho VM; Brandão ML; Nobre MJ
    Prog Neuropsychopharmacol Biol Psychiatry; 2008 Apr; 32(3):794-802. PubMed ID: 18281136
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evaluation of anxiolytic effect and withdrawal anxiety in chronic intermittent diazepam treatment in rats.
    Açikmeşe B; Haznedar S; Hatipoğlu I; Enginar N
    Behav Pharmacol; 2012 Apr; 23(2):215-9. PubMed ID: 22327020
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Assessment of afobazole effects on diazepam withdrawal-induced anxiety in rats].
    Eksp Klin Farmakol; 2014; 77(4):6-9. PubMed ID: 25076752
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Role of the cholecystokinin system in anxiolytic activity of dipeptide GB-115.
    Kolik LG; Gudasheva TA; Seredenin SB
    Bull Exp Biol Med; 2012 Oct; 153(6):851-4. PubMed ID: 23113301
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Sensitisation of withdrawal signs following repeated withdrawal from a benzodiazepine: differences between measures of anxiety and seizure sensitivity.
    Ward BO; Stephens DN
    Psychopharmacology (Berl); 1998 Feb; 135(4):342-52. PubMed ID: 9539258
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Antidepressants attenuate both the enhanced ethanol intake and ethanol-induced anxiolytic effects in diazepam withdrawn rats.
    Martijena ID; Bustos SG; Bertotto ME; Molina VA
    Eur Neuropsychopharmacol; 2005 Jan; 15(1):119-30. PubMed ID: 15572281
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Glutamate receptor antagonism in inferior colliculus attenuates elevated startle response of high anxiety diazepam-withdrawn rats.
    Cabral A; De Ross J; Castilho VM; Brandão ML; Nobre MJ
    Neuroscience; 2009 Jul; 161(3):707-17. PubMed ID: 19348870
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [EXPERIMENTAL PHARMACOKINETICS AND PHARMACODYNAMICS OF GB-115 DIPEPTIDE ANXIOLYTIC SUBSTANCES].
    Kolik LG; Zherdev VP; Boiko SS; Konstantinopol'skii MA; Raskin SY; Gudasheva TA; Mart'yanov VA; Seredenin SB
    Eksp Klin Farmakol; 2015; 78(11):30-4. PubMed ID: 27017703
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Topiramate reduces basal anxiety and relieves ethanol withdrawal-induced anxious behaviors in male rats.
    Junqueira-Ayres DD; Asth L; Ayres AS; Lobão-Soares B; Soares-Rachetti VP; Gavioli EC
    Exp Clin Psychopharmacol; 2017 Apr; 25(2):105-113. PubMed ID: 28287793
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Lack of tolerance to anxiolysis and withdrawal symptoms in mice repeatedly treated with AC-5216, a selective TSPO ligand.
    Kita A; Kinoshita T; Kohayakawa H; Furukawa K; Akaike A
    Prog Neuropsychopharmacol Biol Psychiatry; 2009 Aug; 33(6):1040-5. PubMed ID: 19497344
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [The anxiolytic effect of small cumulative doses of oxypertin in rats during the anxiety test and their possible neurochemical correlates in the hypothalamus and striatum].
    Nitsch F; Hassler R; Kim JS; Bak IJ
    Nervenarzt; 1976 Jan; 47(1):40-5. PubMed ID: 2888
    [No Abstract]   [Full Text] [Related]  

  • 15. Attenuation of benzodiazepine withdrawal anxiety in the rat by serotonin antagonists.
    Begg DP; Hallam KT; Norman TR
    Behav Brain Res; 2005 Jun; 161(2):286-90. PubMed ID: 15922055
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Design and synthesis of cholecystokinin-4 dipeptide analogues with anxiolytic and anxiogenic activities].
    Gudasheva TA; Kir'ianova EP; Kolik LG; Konstantinopol'skiĭ MA; Seredenin SB
    Bioorg Khim; 2007; 33(4):413-20. PubMed ID: 17886432
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Dopamine D3 receptor knock-out mice exhibit increased behavioral sensitivity to the anxiolytic drug diazepam.
    Leggio GM; Micale V; Le Foll B; Mazzola C; Nobrega JN; Drago F
    Eur Neuropsychopharmacol; 2011 Apr; 21(4):325-32. PubMed ID: 20627473
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [The anxiolytic effect of ondansetron and its capacity to eliminate the benzodiazepine abstinence syndrome in rats].
    Garibova TL; Voronina TA; Kraĭneva VA; Val'dman EA
    Eksp Klin Farmakol; 1999; 62(6):16-9. PubMed ID: 10650519
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Withdrawal syndrome following subchronic treatment with anxiolytic agents.
    Barry JM; Costall B; Kelly ME; Naylor RJ
    Pharmacol Biochem Behav; 1987 Jun; 27(2):239-45. PubMed ID: 2888134
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Effects of new amino acid derivates of dopamine on anxiety-like behavior].
    Fedotova IuO; Barishpolets VV; Sapronov NS
    Eksp Klin Farmakol; 2012; 75(6):14-22. PubMed ID: 22891436
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.